Hepatocellular Carcinoma in the World and the Middle East
Authors:
Open Access
- 1 January 2010
- journal article
- review article
- Vol. 2 (1) , 31-41
Abstract
Hepatocellular carcinoma (HCC) is a major worldwide public health concern. Despite recent advances, there has been little success in improving the survival of HCC patients. Due to advances in diagnostic modalities and the increasing incidence of chronic viral hepatitis and nonalcoholic fatty liver disease (NAFLD), both of which are well known risk factors of HCC, the prevalence of HCC is increasing in developed countries and it is expected that this trend will continue in the future.Keywords
This publication has 106 references indexed in Scilit:
- The association of complex liver disorders with HBV genotypes prevalent in PakistanVirology Journal, 2007
- Genotypes of hepatitis C virus (HCV) among positive Lebanese patients: comparison of data with that from other Middle Eastern countriesEpidemiology and Infection, 2006
- Molecular epidemiology of hepatitis B, C and D viruses in Turkish patientsArchives of Virology, 2004
- Cancer mortality in Europe, 1995–1999, and an overview of trends since 1960International Journal of Cancer, 2004
- Hepatocellular carcinoma and hepatitis C in the United StatesHepatology, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Global cancer statistics in the year 2000The Lancet Oncology, 2001
- Modelling the hepatitis C virus epidemic in AustraliaJournal of Gastroenterology and Hepatology, 1999
- Time trends and age-period-cohort effects on the incidence of primary liver cancer in a well-defined French population: 1976–1995Journal of Hepatology, 1998
- Dietary iron overload as a risk factor for hepatocellular carcinoma in black africansHepatology, 1998